{"title":"Indications, Interpretation and Clinical Consequences of Tuberculin Skin Tests in Resource Limited Settings","authors":"F. Gopie, A. Hassankhan, W. Zijlmans, S. Vreden","doi":"10.4236/jtr.2021.93016","DOIUrl":null,"url":null,"abstract":"Objective: to evaluate the policy of TST testing in Suriname. As there is no gold \nstandard to diagnose latent tuberculosis infection (LTBI), the tuberculin skin \ntest (TST) is used to diagnose LTBI. However, internationally, the cut-off \nvalues of the TST are not uniform and depend on local tuberculosis (TB) \nepidemiology and guidelines for test initiation. In Suriname, where currently several \nindications exist for TSTs, cut-off values are set at 5 mm or 10 mm, depending \non the age and/or medical history of the patient. LTBI classification is \nperformed by pulmonologists primarily based on the American Thoracic Society \ntargeted TB testing guidelines. Method: retrospective \nanalysis of outpatient TST data between 2011 and 2019 from Suriname’s sole \npulmonary medicine clinic. Result: 1373 patients were \nevaluated. 590 patients were from the screening group of whom 253 had a \npositive TST result, 46 of whom were classified as LTBI. In the contact tracing \ngroup of 649 patients, 616 had a positive TST, 352 of whom were classified as \nLTBI. In the medical condition group of 134 patients, 96 had a positive TST, 38 \nof whom were classified as LTBI. Eventually, positive TST results were found \nfor 965 tested patients: 436 patients were classified as LTBI and 529 non-LTBI \npatients were not prescribed chemoprophylaxis. None of the non-LTBI \nTST-positive patients were diagnosed with active TB, including 174 patients \nwith a TST result of 15 mm or greater and in need of IPT, but not prescribed by \njudgement of the pulmonologist or because of loss to follow-up. Conclusion: the overrepresentation of positive TST results in Suriname is attributable \nto stringent cut-off values, especially among patients who do not disclose TB \nrisk factors. In our opinion the TST cut-off value for such patients in \nSuriname and other similar settings could be set at 15 mm. We also promote that \nfor all patients with a TST result of 15 mm or greater, offering IPT should be \nconsidered (after excluding active TB).","PeriodicalId":70603,"journal":{"name":"结核病研究(英文)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"结核病研究(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/jtr.2021.93016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: to evaluate the policy of TST testing in Suriname. As there is no gold
standard to diagnose latent tuberculosis infection (LTBI), the tuberculin skin
test (TST) is used to diagnose LTBI. However, internationally, the cut-off
values of the TST are not uniform and depend on local tuberculosis (TB)
epidemiology and guidelines for test initiation. In Suriname, where currently several
indications exist for TSTs, cut-off values are set at 5 mm or 10 mm, depending
on the age and/or medical history of the patient. LTBI classification is
performed by pulmonologists primarily based on the American Thoracic Society
targeted TB testing guidelines. Method: retrospective
analysis of outpatient TST data between 2011 and 2019 from Suriname’s sole
pulmonary medicine clinic. Result: 1373 patients were
evaluated. 590 patients were from the screening group of whom 253 had a
positive TST result, 46 of whom were classified as LTBI. In the contact tracing
group of 649 patients, 616 had a positive TST, 352 of whom were classified as
LTBI. In the medical condition group of 134 patients, 96 had a positive TST, 38
of whom were classified as LTBI. Eventually, positive TST results were found
for 965 tested patients: 436 patients were classified as LTBI and 529 non-LTBI
patients were not prescribed chemoprophylaxis. None of the non-LTBI
TST-positive patients were diagnosed with active TB, including 174 patients
with a TST result of 15 mm or greater and in need of IPT, but not prescribed by
judgement of the pulmonologist or because of loss to follow-up. Conclusion: the overrepresentation of positive TST results in Suriname is attributable
to stringent cut-off values, especially among patients who do not disclose TB
risk factors. In our opinion the TST cut-off value for such patients in
Suriname and other similar settings could be set at 15 mm. We also promote that
for all patients with a TST result of 15 mm or greater, offering IPT should be
considered (after excluding active TB).